ELEM Biotech Participated in EUCROF26, the 9th Annual Conference, which took place 1–3 February 2026 in Amsterdam, the Netherlands.
About the event
How are new technologies improving trial efficiency, data quality, drug development, and patient-centric approaches?
EUCROF26 brought together CROs, Pharma, but also regulatory authorities, biotech innovators, and patient focused organizations, from across Europe and beyond for three days of networking, expert-led sessions, and future-focused discussions aimed at accelerating innovation in clinical research.
ELEM at EUCROF26!
We partecipated to the conference with a presentation:
Breakout 8: Digital Transformation of Clinical Research
Our scientist Jazmine Auado-Sierra explained how Virtual clinical trials provide a holistic approach to the evaluation of cardiac drug safety from the earliest stages of lead optimisation to the pre-clinical, clinical and safety surveillance of drugs.
Here some of the main trends highlighted during the event regarding Clinical research Innvoation:
1 – Trials need to be patient centric
2 – Regulatory and strategic initiatives are boosting Europe’s Clinical Research competitiveness
3 – Trial design needs to innovate to improve efficiency and patient outcomes.
Curious to understand which evidence for cardiac safety can be provided by testing drugs and devices on ELEM platforms?
